Page last updated: 2024-08-24

ranolazine and Coronary Thrombosis

ranolazine has been researched along with Coronary Thrombosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boden, WE; Friedewald, VE; Roberts, WC; Stone, GW; Yancy, CW	1

Other Studies

1 other study(ies) available for ranolazine and Coronary Thrombosis

Article	Year
The editor's roundtable: role of percutaneous coronary intervention and drug-eluting stents in patients with stable coronary heart disease. The American journal of cardiology, 2011, Nov-15, Volume: 108, Issue:10 Topics: Acetanilides; Acute Coronary Syndrome; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antithrombins; C-Reactive Protein; Cholesterol, LDL; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Cost-Benefit Analysis; Diabetes Mellitus; Drug-Eluting Stents; Enzyme Inhibitors; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Medical History Taking; Medication Adherence; Multidetector Computed Tomography; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Radionuclide Imaging; Ranolazine; Risk Factors; Troponin	2011

Article

Year

The editor's roundtable: role of percutaneous coronary intervention and drug-eluting stents in patients with stable coronary heart disease.

The American journal of cardiology, 2011, Nov-15, Volume: 108, Issue:10

Topics: Acetanilides; Acute Coronary Syndrome; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antithrombins; C-Reactive Protein; Cholesterol, LDL; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Cost-Benefit Analysis; Diabetes Mellitus; Drug-Eluting Stents; Enzyme Inhibitors; Heart; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Medical History Taking; Medication Adherence; Multidetector Computed Tomography; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Radionuclide Imaging; Ranolazine; Risk Factors; Troponin

2011